HRP20181352T1 - Postupci i reagensi za održavanje vijabilnosti stanica raka u kirurški odstranjenom tkivu - Google Patents

Postupci i reagensi za održavanje vijabilnosti stanica raka u kirurški odstranjenom tkivu

Info

Publication number
HRP20181352T1
HRP20181352T1 HRP20181352TT HRP20181352T HRP20181352T1 HR P20181352 T1 HRP20181352 T1 HR P20181352T1 HR P20181352T T HRP20181352T T HR P20181352TT HR P20181352 T HRP20181352 T HR P20181352T HR P20181352 T1 HRP20181352 T1 HR P20181352T1
Authority
HR
Croatia
Prior art keywords
tissue
reagents
cancer
procedures
maintenance
Prior art date
Application number
HRP20181352TT
Other languages
English (en)
Croatian (hr)
Inventor
Tony K. Baker
Original Assignee
Truckee Applied Genomics, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Truckee Applied Genomics, Llc filed Critical Truckee Applied Genomics, Llc
Publication of HRP20181352T1 publication Critical patent/HRP20181352T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Physiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
HRP20181352TT 2013-03-15 2014-03-14 Postupci i reagensi za održavanje vijabilnosti stanica raka u kirurški odstranjenom tkivu HRP20181352T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361798627P 2013-03-15 2013-03-15
EP14763797.9A EP2970878B1 (en) 2013-03-15 2014-03-14 Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue
PCT/US2014/029198 WO2014144682A1 (en) 2013-03-15 2014-03-14 Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue

Publications (1)

Publication Number Publication Date
HRP20181352T1 true HRP20181352T1 (hr) 2018-12-14

Family

ID=51528685

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181352TT HRP20181352T1 (hr) 2013-03-15 2014-03-14 Postupci i reagensi za održavanje vijabilnosti stanica raka u kirurški odstranjenom tkivu

Country Status (17)

Country Link
US (5) US9113623B2 (enExample)
EP (2) EP3581643A1 (enExample)
JP (1) JP6465857B2 (enExample)
CN (2) CN105121629B (enExample)
CA (1) CA2941929C (enExample)
CY (1) CY1120801T1 (enExample)
DK (1) DK2970878T3 (enExample)
ES (1) ES2684582T3 (enExample)
HR (1) HRP20181352T1 (enExample)
HU (1) HUE039933T2 (enExample)
LT (1) LT2970878T (enExample)
PL (1) PL2970878T3 (enExample)
PT (1) PT2970878T (enExample)
RS (1) RS57900B1 (enExample)
SI (1) SI2970878T1 (enExample)
SM (1) SMT201800457T1 (enExample)
WO (1) WO2014144682A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105121629B (zh) 2013-03-15 2020-12-18 特拉基应用基因组学有限责任公司 用于保持已手术去除的组织中的癌细胞活力的方法和试剂
US10053676B2 (en) 2014-11-25 2018-08-21 Bio-Rad Laboratories, Inc. Arginine improves polymerase storage stability
CN107333750A (zh) * 2017-06-11 2017-11-10 成都吱吖科技有限公司 一种长时血液细胞稳定剂
WO2021055170A1 (en) * 2019-09-17 2021-03-25 Longhorn Vaccines And Diagnostics, Llc Multipurpose compositions for collecting and transporting biological material
WO2022010916A1 (en) * 2020-07-07 2022-01-13 Truckee Applied Genomics, Llc Cell preservation reagents and methods of use
CN117063915B (zh) * 2023-08-17 2026-02-24 镜像绮点(上海)细胞技术有限公司 原代肿瘤细胞冻存液

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409826A (en) * 1993-06-08 1995-04-25 Coulter Corporation Preserved, non-infectious control cells prepared by the modulation or modification of normal cells
JP2000509018A (ja) * 1996-03-26 2000-07-18 イーライ・リリー・アンド・カンパニー 肥満タンパク質製剤
US20010007673A1 (en) 1999-11-12 2001-07-12 Merrill Seymour Goldenberg Sustained-release delayed gels
JP2001526051A (ja) 1997-12-10 2001-12-18 シエラ ダイアグノスティクス,インク. 体液中のdnaを保存するための方法及び試薬
US20080064108A1 (en) 1997-12-10 2008-03-13 Tony Baker Urine Preservation System
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
CN1230524C (zh) * 2000-12-04 2005-12-07 株式会社淋巴技术 细胞保存液和使用该保存液的细胞保存方法
KR20020066778A (ko) 2001-02-13 2002-08-21 한국과학기술연구원 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법
WO2008111981A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation of macromolecules
AU2003300899A1 (en) * 2002-12-12 2004-06-30 Oncotech, Inc. Genes related to sensitivity and resistance to chemotherapeutic drug treatment
US8793895B2 (en) * 2006-02-10 2014-08-05 Praxair Technology, Inc. Lyophilization system and method
US8080645B2 (en) * 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
CN101617045A (zh) 2006-09-12 2009-12-30 谢拉分子公司 使用离液剂的缓冲溶液去除核酸的分子分析干扰物
US8652782B2 (en) * 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
EP2086622A2 (en) 2006-10-27 2009-08-12 Sierra Molecular Corporation Penetratable septum cap
WO2008071384A1 (en) 2006-12-13 2008-06-19 Roche Diagnostics Gmbh Use of tde for the isolation of nucleic acids
CA2680801A1 (en) 2007-03-14 2008-09-18 Sierra Molecular Corporation Compositions, systems, and methods for preservation and/or stabilizationof a cell and/or macromolecule
AU2008321382A1 (en) * 2007-11-12 2009-05-22 Bipar Sciences, Inc. Treatment of uterine cancer and ovarian cancer with a PARP inhibitor alone or in combination with anti-tumor agents
WO2010003037A2 (en) * 2008-07-03 2010-01-07 Sierra Molecular Corporation Compositions, systems, and methods for stabilization of a cell and/or macromolecule
WO2010028156A2 (en) 2008-09-04 2010-03-11 Board Of Regents, The University Of Texas System Dual modality detection of apoptosis
US9133343B2 (en) * 2009-11-30 2015-09-15 Enzo Biochem, Inc. Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications
CN102318597B (zh) * 2011-08-19 2013-04-03 张雪云 一种液基细胞保存液组合物及其制备方法
CN105121629B (zh) 2013-03-15 2020-12-18 特拉基应用基因组学有限责任公司 用于保持已手术去除的组织中的癌细胞活力的方法和试剂

Also Published As

Publication number Publication date
WO2014144682A8 (en) 2015-08-13
HUE039933T2 (hu) 2019-02-28
US20150327539A1 (en) 2015-11-19
ES2684582T3 (es) 2018-10-03
JP6465857B2 (ja) 2019-02-06
CA2941929C (en) 2021-02-23
US9949474B2 (en) 2018-04-24
SI2970878T1 (sl) 2019-02-28
HK1220481A1 (en) 2017-05-05
SMT201800457T1 (it) 2018-11-09
WO2014144682A4 (en) 2014-12-24
US10772318B2 (en) 2020-09-15
US20160235055A1 (en) 2016-08-18
US9113623B2 (en) 2015-08-25
EP3581643A1 (en) 2019-12-18
US20150230454A1 (en) 2015-08-20
RS57900B1 (sr) 2019-01-31
US9445586B2 (en) 2016-09-20
EP2970878B1 (en) 2018-05-23
DK2970878T3 (en) 2018-09-03
LT2970878T (lt) 2018-11-12
EP2970878A1 (en) 2016-01-20
US20170215410A1 (en) 2017-08-03
CN105121629B (zh) 2020-12-18
CN105121629A (zh) 2015-12-02
PL2970878T3 (pl) 2019-01-31
PT2970878T (pt) 2018-10-09
CA2941929A1 (en) 2014-09-18
US9565852B2 (en) 2017-02-14
CN112806352A (zh) 2021-05-18
EP2970878A4 (en) 2016-08-03
US20140272921A1 (en) 2014-09-18
JP2016512693A (ja) 2016-05-09
WO2014144682A1 (en) 2014-09-18
CY1120801T1 (el) 2019-12-11

Similar Documents

Publication Publication Date Title
IL246141A0 (en) Methods for adhering tissue surfaces and materials and biomedical uses thereof
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
ME02911B (me) Derivati c17 heteroarila oleanolinske kisjeline i postupci za njihovu upotrebu
HRP20260139T1 (hr) Farmaceutski pripravak, postupci za liječenje i njegove uporabe
IL239007B (en) Eribulin for use in the treatment of breast cancer
IL245337B (en) Combinations of checkpoint inhibitors and therapeutics to treat cancer
HRP20181994T1 (hr) Neuroaktivni steroidi i postupci za njihovu upotrebu
HRP20180817T1 (hr) Sastavi i postupci za modulaciju farnesoid-x-receptora
HRP20181302T1 (hr) Terapija za obnavljanje mikrobiota (mrt), pripravci i postupci proizvodnje
IL243408A0 (en) Diagnosis and therapy of cancer involving cancer stem cells
SI2981822T1 (sl) Sestavki in postopki za modulacijo rastnega dejavnika
IL242394B (en) Cenicriviroc compositions and methods of making and using the same
HRP20180126T1 (hr) Pripravci pcsk9 irna i postupci njihove upotrebe
PL3489261T3 (pl) Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
HRP20170840T1 (hr) Supstituirani ksantini i metode njihove uporabe
HRP20171365T1 (hr) Terapeutske polimerne nanočestice i postupci dobivanja i njihovog korištenja
IL239453B (en) Compositions and methods for treatment of cancer using bacteria
SI3036258T1 (sl) Modulacija imunoreceptorjev za zdravljenje raka in virusnih infekcij
DE112013005641A5 (de) Vorrichtung zur insbesondere transperinealen Untersuchung von Patienten
HRP20180729T1 (hr) Derivati sulfonil piperidina i njihova uporaba za liječenje bolesti posredovanih prokinetikinom
HRP20182138T1 (hr) Modificirani serpini za liječenje poremećaja s krvarenjem
PL3200815T3 (pl) Sposoby i kompozycje do leczenia nowotworu
IL246269B (en) Compositions and methods for treating fatty tissue buildup
EP2958571C0 (en) DNA HYPOMETHYLING AGENTS FOR CANCER THERAPY
HRP20160879T1 (hr) Pripravci i postupci za moduliranje kinaze